These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35079901)

  • 21. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.
    Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
    mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation.
    Yu S; Zheng X; Zhou B; Li J; Chen M; Deng R; Wong G; Lavillette D; Meng G
    Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34930824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia.
    Zou W; Xiong M; Hao S; Zhang EY; Baumlin N; Kim MD; Salathe M; Yan Z; Qiu J
    mBio; 2021 May; 12(3):. PubMed ID: 33975939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein.
    Kleine-Weber H; Elzayat MT; Hoffmann M; Pöhlmann S
    Sci Rep; 2018 Nov; 8(1):16597. PubMed ID: 30413791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
    J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain.
    Beaudoin CA; Pandurangan AP; Kim SY; Hamaia SW; Huang CL; Blundell TL; Vedithi SC; Jackson AP
    J Med Virol; 2022 Sep; 94(9):4181-4192. PubMed ID: 35575289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.
    Nguyen HT; Zhang S; Wang Q; Anang S; Wang J; Ding H; Kappes JC; Sodroski J
    J Virol; 2021 Mar; 95(5):. PubMed ID: 33310888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
    Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
    mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of host proteases in the entry of SARS-CoV-2.
    Zabiegala A; Kim Y; Chang KO
    Anim Dis; 2023; 3(1):12. PubMed ID: 37128508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation of Proteolytic Cleavage Sites towards the N-Terminal End of the S2 Subunit of the Novel SARS-CoV-2 Omicron Sublineage BA.2.12.1.
    Schilling NA; Kalbacher H; Burster T
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivity.
    Khatri R; Lohiya B; Kaur G; Maithil V; Goswami A; Sarmadhikari D; Asthana S; Samal S
    3 Biotech; 2023 Oct; 13(10):323. PubMed ID: 37663753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SKI-1/S1P Facilitates SARS-CoV-2 Spike Induced Cell-to-Cell Fusion via Activation of SREBP-2 and Metalloproteases, Whereas PCSK9 Enhances the Degradation of ACE2.
    Essalmani R; Andréo U; Evagelidis A; Le Dévéhat M; Pereira Ramos OH; Fruchart Gaillard C; Susan-Resiga D; Cohen ÉA; Seidah NG
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion.
    Li CJ; Chao TL; Chang TY; Hsiao CC; Lu DC; Chiang YW; Lai GC; Tsai YM; Fang JT; Ieong S; Wang JT; Chang SY; Chang SC
    Microbiol Spectr; 2022 Apr; 10(2):e0181421. PubMed ID: 35293796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis.
    Vu MN; Lokugamage KG; Plante JA; Scharton D; Bailey AO; Sotcheff S; Swetnam DM; Johnson BA; Schindewolf C; Alvarado RE; Crocquet-Valdes PA; Debbink K; Weaver SC; Walker DH; Russell WK; Routh AL; Plante KS; Menachery VD
    Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2205690119. PubMed ID: 35881779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolytic activation of the spike protein at a novel RRRR/S motif is implicated in furin-dependent entry, syncytium formation, and infectivity of coronavirus infectious bronchitis virus in cultured cells.
    Yamada Y; Liu DX
    J Virol; 2009 Sep; 83(17):8744-58. PubMed ID: 19553314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An engineered 5-helix bundle derived from SARS-CoV-2 S2 pre-binds sarbecoviral spike at both serological- and endosomal-pH to inhibit virus entry.
    Lin X; Guo L; Lin S; Chen Z; Yang F; Yang J; Wang L; Wen A; Duan Y; Zhang X; Dai Y; Yin K; Yuan X; Yu C; He B; Cao Y; Dong H; Li J; Zhao Q; Lu G
    Emerg Microbes Infect; 2022 Dec; 11(1):1920-1935. PubMed ID: 35757908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry.
    Sengar A; Cervantes M; Bondalapati ST; Hess T; Kasson PM
    J Virol; 2023 May; 97(5):e0199222. PubMed ID: 37133381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tight junction protein occludin is an internalization factor for SARS-CoV-2 infection and mediates virus cell-to-cell transmission.
    Zhang J; Yang W; Roy S; Liu H; Roberts RM; Wang L; Shi L; Ma W
    Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2218623120. PubMed ID: 37068248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
    Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
    mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site.
    Jaimes JA; Millet JK; Whittaker GR
    SSRN; 2020 May; ():3581359. PubMed ID: 32714113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.